World Library  
Flag as Inappropriate
Email this Article

Nomegestrol acetate

Article Id: WHEBN0026791100
Reproduction Date:

Title: Nomegestrol acetate  
Author: World Heritage Encyclopedia
Language: English
Subject: Nomegestrol, Progestogen only contraception, Cyproterone acetate, Progestogens, Hormonal contraception
Collection:
Publisher: World Heritage Encyclopedia
Publication
Date:
 

Nomegestrol acetate

Nomegestrol acetate
Systematic (IUPAC) name
(17α)-17-acetyl-6-methyl-3-oxoestra-4,6-dien-17-yl acetate
Clinical data
Legal status
  • Prescription only
Routes Oral
Identifiers
CAS number
ATC code G03
PubChem
ChemSpider
Chemical data
Formula C23H30O4 
Mol. mass 370.482 g/mol

Nomegestrol acetate (INN; Lutenyl), or 19-normegestrol acetate, is a steroidal progestin with additional antigonadotropic effects which was introduced in 1986 and is used as a hormonal contraceptive.[1][2] Unlike many other steroidal progestogens, it is selective for the progesterone receptor, lacking any significant affinity for other steroid receptors such as the androgen, estrogen, glucocorticoid, and mineralocorticoid receptors. As a result, it does not possess any androgenic, estrogenic, glucocorticoid, or mineralocorticoid effects. However, at sufficiently high doses it does have potent antiestrogenic and antiandrogenic effects due to its progesterone receptor-mediated antigonadotropic properties.[3][4]

The combination with estradiol is also used as a hormonal contraceptive and approved in Europe under the name Zoely.[5]

More information

  • http://www.zoely.co.uk

See also

References

  1. ^ F.. Macdonald (1997). Dictionary of Pharmacological Agents. CRC Press. p. 1445.  
  2. ^ Jamin C, Batallan A, Madelenat P (January 2003). "[Antigonadotropic effects of a 19-nor-progesterone derivative: the example of nomegestrol acetate]". Gynécologie, Obstétrique & Fertilité (in French) 31 (1): 70–81.  
  3. ^ Lello S (March 2010). "Nomegestrol acetate: pharmacology, safety profile and therapeutic efficacy". Drugs 70 (5): 541–59.  
  4. ^ Paris J, Thévenot R, Bonnet P, Granero M (1983). "The pharmacological profile of TX 066 (17 alpha-acetoxy-6-methyl-19-nor-4,6-pregna-diene-3,20-dione), a new oral progestative". Arzneimittel-Forschung 33 (5): 710–5.  
  5. ^ European Medicines Agency: Zoely


This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and USA.gov, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for USA.gov and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
 
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
 
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.
 


Copyright © World Library Foundation. All rights reserved. eBooks from Project Gutenberg are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.